Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Telangiectasia Type 2”

14 trials

Showing 14 of 14 results

Testing effectiveness (Phase 2)Study completedNCT04907084
What this trial is testing

Serine and Fenofibrate Study in Patients With MacTel Type 2

Who this might be right for
Macular Telangiectasia Type 2
The Lowy Medical Research Institute Limited 89
Testing effectiveness (Phase 2)Study completedNCT03669393
What this trial is testing

Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1)

Who this might be right for
Retinal TelangiectasisIdiopathic Juxtafoveal Retinal Telangiectasia
ThromboGenics 8
Early research (Phase 1)Study completedNCT01327911
What this trial is testing

Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel)

Who this might be right for
Idiopathic Juxtafoveal Telangiectasia
Neurotech Pharmaceuticals 7
Large-scale testing (Phase 3)Study completedNCT03319849
What this trial is testing

Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol B

Who this might be right for
Macular Telangiectasia Type 2
Neurotech Pharmaceuticals 119
Testing effectiveness (Phase 2)Study completedNCT01949324
What this trial is testing

Multicenter Randomized Clinical Trial of CNTF for MacTel

Who this might be right for
Macular Telangiectasia Type 2
Neurotech Pharmaceuticals 67
Not applicableStudy completedNCT03321916
What this trial is testing

MacTel Laser Study

Who this might be right for
Macular Telangiectasia
The Lowy Medical Research Institute Limited 9
Not applicableStudy completedNCT01354093
What this trial is testing

The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)

Who this might be right for
Idiopathic Juxtafoveal Telangiectasia
Paul S. Bernstein 8
Large-scale testing (Phase 3)Study completedNCT03316300
What this trial is testing

Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A

Who this might be right for
Macular Telangiectasia Type 2 (MacTel)
Neurotech Pharmaceuticals 120
Large-scale testing (Phase 3)Active Not RecruitingNCT06397131
What this trial is testing

Determine the Safety and Efficacy of NT-501 With MHFM

Who this might be right for
Macular Telangiectasia Type 2
Neurotech Pharmaceuticals 12
Post-approval studies (Phase 4)Looking for participantsNCT06971939
What this trial is testing

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

Who this might be right for
Macular Telangiectasia Type 2 (MacTel)
Neurotech Pharmaceuticals 234
Large-scale testing (Phase 3)Not Yet RecruitingNCT07342439
What this trial is testing

Study of Serine Supplementation to Protect Vision in MacTel

Who this might be right for
Macular Telangiectasia Type 2 (MacTel)
The Lowy Medical Research Institute Limited 120
Testing effectiveness (Phase 2)Study completedNCT00504400
What this trial is testing

Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)

Who this might be right for
Type 2 Idiopathic Macular Telangiectasia
University Hospital, Bonn 10
Testing effectiveness (Phase 2)Study completedNCT03071965
What this trial is testing

Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)

Who this might be right for
MacTel (Macular Telangiectasia) Type 2
Neurotech Pharmaceuticals 70
Testing effectiveness (Phase 2)Study completedNCT04729972
What this trial is testing

Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2

Who this might be right for
Macular Telangiectasia Type 2
Neurotech Pharmaceuticals 33

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation